Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Corbus Pharmaceuticals Holding
Today
Create an eToro account to buy CRBP stock on a secure, user-friendly, multi-asset trading platform.
Buy Corbus Pharmaceuticals Holding
CRBP Price
Corbus Pharmaceuticals Holding CRBP
CRBP Price

Corbus Pharmaceuticals Holding CRBP

$12.040.24(2.03%)(1D)

CRBP Stock Price Chart

-32.77%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Corbus Pharmaceuticals Holding share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Corbus Pharmaceuticals Holding share price today is 12.04, reflecting a 2.03% change over the last 24 hours and -8.52% over the past week. The current market capitalization of CRBP is 146.64M with an average volume in the last three months of 342778.27. The stock has a P/E ratio of -2.56 and a dividend yield of 0%. With the stock’s beta sitting at 1.31
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$146.64M

Day’s Range
i
Shows the high and low prices of the day.
11.48 - 15.16

52W Range
i
Shows the high and low prices of the last year.
3.07 - 61.51

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
342778.27

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-2.56

Revenue
i
The total income generated by this company’s goods and services last year.
$0

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$12.04

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-4.69

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.31

What Is Corbus Pharmaceuticals Holding?
Corbus Pharmaceuticals Holdings Inc. is an American clinical-stage pharmaceutical company with a specialisation in immunology. Operating globally, the firm is primarily focused on the discovery, development, and commercialisation of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Diseases in this category include sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The firm was founded in 2009 and has its corporate headquarters in Norwood, Massachusetts.

The firm’s specific therapeutic focus areas are immuno-oncology, metabolism, inflammation, and fibrosis. The Corbus Pharmaceuticals team is engaged in the development of a diverse pipeline of drug candidates, including small molecule therapies as well as biologics. The company's lead product candidate, Lenabasum, is a novel synthetic oral cannabinoid receptor type 2 (CB2) agonist, which is used to treat chronic inflammation, limit fibrosis, and support tissue repair.

Corbus Pharmaceuticals is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. Other products in the company’s pipeline are at various clinical phases and target solid tumours, fibrosis, and metabolism disorders. The firm is listed on the NASDAQ, where it trades under the stock ticker CRBP.

Track changes in the Corbus Pharmaceuticals share price when you add CRBP stock to your eToro watchlist.

How can I buy Corbus Pharmaceuticals Holding stocks?

To purchase Corbus Pharmaceuticals Holding:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Corbus Pharmaceuticals Holding (CRBP) page and place an order to buy Corbus Pharmaceuticals Holding.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Corbus Pharmaceuticals Holding
Invest in Corbus Pharmaceuticals Holding
Today
Create an eToro account to buy CRBP stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of CRBP is 12.04.
The average price target for Corbus Pharmaceuticals Holding is 12.04. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Corbus Pharmaceuticals Holding based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Corbus Pharmaceuticals Holding is 146.64M
Scroll to top